Healio Rheumatology


The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents

EULAR Launches COVID-19 Rheumatic Disease Reporting Database

Cover Story

Redrawing the Dividing Line in Nonradiographic axSpA

Drug Pipeline

FDA Clears Novartis to Open Hydroxychloroquine Trial for COVID-19

FDA Grants Fast Track Status to Telitacicept for SLE

FDA Approves Store Brand Equivalent of Voltaren

FDA Approves Hydroxychloroquine New Drug Application to Address COVID-19 Related Shortage

FDA Allows Emergency Use of Blood Purification Technology to Treat Cytokine Storm in COVID-19


The Rheumatologist and Medical Education in the Time of COVID-19

Leonard H. Calabrese, DO


Rheumatologists, Pharmacists Debate ‘Right to Try’ Hydroxychloroquine for COVID-19

FDA’s Hydroxychloroquine Emergency Use Order for COVID-19 Draws Mixed Reactions

Breathing ‘Rheum’ in COVID-19 Hotspots: New Orleans Finds New ‘Camaraderie’ Amid Economic Bust


Updated EULAR Recommendations Revamp Treatment Targets for Lupus Nephritis

ACR: Suspend Immunosuppressants, Select DMARDs in Rheumatic Patients With COVID-19

Healio CME

Systemic Lupus Erythematosus Curbside Consults: Managing a Patient With Renal Involvement

In the Journals

COVID-19 Global Rheumatology Alliance Discourages Off-label Use of Hydroxychloroquine

Sprifermin Increases Cartilage Thickness, Reduces Loss in Knee OA

Neither First Nor Second Biologic Beneficial for Many With JIA

Abortion Does not Worsen Rheumatic Disease Outcomes

Childhood Sexual, Physical Abuse Increases Adulthood Lupus Risk Among Black Women

Meeting News

Rheumatologists Move ‘Front and Center’ in Fight Against COVID-19

COVID-19 Threatens Rheumatology Practices Amid Plunging Patient Volume, Revenue

Origin Stories

From the Throat to the Heart: Charting the Long History of Rheumatic Fever


Arthritis Foundation’s ‘Live Yes!’ Leverages Patient Input to Enhance Arthritis Trials, Potential Therapies

Q&A With Healio Rheumatology

Weathering the Cytokine Storm in COVID-19: Telltale Signs, Therapeutic Hope on the Horizon

Trend Watch

Physical Therapy Superior to Glucocorticoid Injection for OA Pain, Functional Disability

ACR Calls for Eliminating Redundancies in Prior Authorization

Asthma, COPD Linked With Increased Risk for RA in Women

Glucocorticoids, Not Biologics, Increase Adverse Outcome Risk After Major Surgery in RA